Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Human IgG4 Antibody (R1B90)

Catalog #:   RHJ93112 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IHC, WB
Accession: P01861
Overview

Catalog No.

RHJ93112

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IHC: 1:100-1:200, WB: 1:1000-1:2000

Target

Ig gamma 4 chain C region, IGHG4, IGG4, Human IgG4

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P01861

Applications

IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4 ℃ short term (1-2 weeks).Store at -20 ℃ 12 months. Store at -80 ℃ long term.

Clone ID

R1B90

Data Image
  • Immunohistochemical
    Immunohistochemical analysis of paraffin-embedded human stomach carcinoma, using human IgG4 Antibody .
  • Western blot
    Western blot analysis of human IgG4 expression in Human spleen lysate.
References

Enhanced visualization of colonic polyps using a fluorophore-conjugated claudin-1 antibody in a CPC-APC mouse model., PMID:40517099

Autoantibody clusters in rheumatoid arthritis are not driven by antigen specificity or isotype., PMID:40514057

Native structure of the monoclonal therapeutic CD20 antibody ocrelizumab., PMID:40513927

High-sensitivity multicancer detection of stage 1 cancer in dogs., PMID:40513713

The waning of maternal measles antibodies: a multi-country maternal-infant seroprevalence study., PMID:40513621

Patrolling monocytes mediate virus neutralizing IgG effector functions: beyond neutralization capacity., PMID:40510351

IgG4-Related Disease: Current and Future Insights into Pathological Diagnosis., PMID:40508133

Leveraging the Polymorphism of the Merozoite Surface Protein 2 (MSP2) to Engineer Molecular Tools for Predicting Malaria Episodes in a Community., PMID:40508084

Rapid detection of SARS-CoV-2 antigen based on IgG colloidal gold immunochromatographic strip., PMID:40506633

Identification of a direct interaction between the Fab domains of IgG antibodies and human FcRn upon IgG-FcRn complex formation., PMID:40506471

FcRn inhibitors in immune thrombocytopenia: A comprehensive review of therapeutic advances and clinical outcomes., PMID:40505332

Clinical Features of Children With MOG-IgG Who Fulfill Criteria of Multiple Sclerosis and Overlapping Disorders., PMID:40505071

Oral Administration of Hydrolyzed Egg Yolk Peptides With Low Molecular Weight Increased Bone Density by Regulating Bone Metabolism and Immune Responses., PMID:40504632

Clinical and prognostic profiles in immune-mediated hypertrophic meningitis: a retrospective analysis of 92 cases., PMID:40504382

An Unusual Presentation of Bullous Skin Lesions During Pregnancy., PMID:40503690

Plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy: a case report and literature review., PMID:40503234

Chronic Inflammatory Demyelinating Polyneuropathy and Concurrent Membranous Nephropathy Associated With Anti-Contactin-1 Autoantibodies: A Rare Case Report With a Review of the Literature., PMID:40502862

[Memoir of Seroepidemiological Study of Helicobacter pylori Infection in Asymptomatic People in South Korea Started in 1997]., PMID:40502309

Oligodendroglia in Neuromyelitis Optica Spectrum Disorder., PMID:40500507

Cytotoxic IgG: Mechanisms, functions, and applications., PMID:40499518

Germline-encoded recognition of peanut underlies development of convergent antibodies in humans., PMID:40498852

Longitudinal SARS-CoV-2 antibody response in a healthcare worker cohort utilising the Abbott Alinity® anti-nucleocapsid assay., PMID:40498754

Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection., PMID:40498720

Seroprevalence of Toxoplasmosis and the Possible Role of C-Reactive Protein in the Pathogenesis of Myocardial Infarction in Patients from Iraq; A Case Control Study., PMID:40498362

Profiling of Anti-glycan IgA and IgG in Oral Fluid Using a Glycan Microarray., PMID:40498306

Periostin: a promising biomarker in nonspecific orbital inflammation and orbit-involving IgG4 disease., PMID:40497932

Efficacy of Subcutaneous Immunoglobulin in the Postoperative Management After Pediatric Living Donor Liver Transplantation., PMID:40495281

Immunoglobulin G4-related ophthalmic disease with orbital deep hemangioma: A case report., PMID:40494658

Evaluating the Effects of 60°C Heating for 90 Min on Bacterial Pathogen Viability and IgG Concentration in Bovine Colostrum., PMID:40493565

Kinetic of the Maternally-Derived Anti-Parvovirus IgG During the Neonatal Period: A Quantitative Assessment., PMID:40493541

Influence of Macrotroponin on the 99th Percentile Threshold in 2 High-Sensitivity Cardiac Troponin Assays., PMID:40492538

Rituximab as First-Line Compared to Escalation Immunotherapy Is Associated With Lower Disability Accumulation in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Cohort Study From Germany and the United Kingdom., PMID:40492480

Design of experiments for the optimization of sample preparation for bottom-up targeted protein LC-MS/MS workflows., PMID:40492479

The real-world safety of Nivolumab: a pharmacovigilance analysis based on the FDA adverse event reporting system., PMID:40491923

Demographic characteristics and disease severity associated with IgA/IgG deposition patterns in autoimmune bullous diseases: a cohort study based on a registry database., PMID:40491920

Dual BLyS/APRIL targeted therapy with telitacicept in rituximab-refractory SLE-associated neuromyelitis optica spectrum disorder: a case report., PMID:40491913

Correlation study between clinical phenotypes and autoantibodies in systemic sclerosis in Southwest China., PMID:40489831

Treatment Patterns and Disease Burden of Juvenile Myasthenia Gravis in the United States: A Cohort Study Using Health Care Claims Databases., PMID:40489715

Elevated eosinophil-to-lymphocyte ratio (ELR) as a predictor of relapse for IgG4-related disease: a retrospective study across a decade., PMID:40488799

Interpretable web-based machine learning model for predicting intravenous immunoglobulin resistance in Kawasaki disease., PMID:40484951

Prevalence, knowledge, attitudes, and practices regarding Chagas disease in Guanare, Venezuela: a cross-sectional study., PMID:40484948

Adaptive immune changes in colorectal cancer: a focus on T and B cell activation genes., PMID:40484866

Vitamin D Deficiency: A Risk Factor for Antibody Decline in COVID-19?, PMID:40484045

Clinical and immunopathological assessment of the oral mucosa in coeliac disease: a pilot study., PMID:40483462

Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathy., PMID:40482854

Development of antibodies against severe fever with thrombocytopenia syndrome virus nucleoprotein for diagnosis., PMID:40481890

Serological analysis of gluten-related antibodies in idiopathic neuropathies and cerebellar ataxia., PMID:40481865

Immune age is correlated with decreased TCR clonal diversity and antibody response to SARS-CoV-2., PMID:40481111

Defining Aedes aegypti density thresholds for preventing human arboviral infections., PMID:40480602

Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy., PMID:40475765

Datasheet
$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human IgG4 Antibody (R1B90) [RHJ93112]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only